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Diversity of biological molecules in newborn and adult immune cells contributes to 
differences in cell function and atopic properties. Micro RNAs (miRNAs) are reported to 
involve in the regulation of immune system. Therefore, determining the miRNA expression 
profile of leukocyte subpopulations is important for understanding immune system reg-
ulation. In order to explore the unique miRNA profiling that contribute to altered immune 
in neonates, we comprehensively analyzed the functional miRNA signatures of eight 
leukocyte subsets (polymorphonuclear cells, monocytes, CD4+ T cells, CD8+ T cells, 
natural killer cells, B cells, plasmacytoid dendritic cells, and myeloid dendritic cells) from 
both neonatal and adult umbilical cord and peripheral blood samples, respectively. We 
observed distinct miRNA profiles between adult and neonatal blood leukocyte subsets, 
including unique miRNA signatures for each cell lineage. Leukocyte miRNA signatures 
were altered after stimulation. Adult peripheral leukocytes had higher let-7b-5p expres-
sion levels compared to neonatal cord leukocytes across multiple subsets, irrespective 
of stimulation. Transfecting neonatal monocytes with a let-7b-5p mimic resulted in a 
reduction of LPS-induced interleukin (IL)-6 and TNF-α production, while transfection of a 
let-7b-5p inhibitor into adult monocytes enhanced IL-6 and TNF-α production. With this 
functional approach, we provide intact differential miRNA expression profiling of specific 
immune cell subsets between neonates and adults. These studies serve as a basis to 
further understand the altered immune response observed in neonates and advance the 
development of therapeutic strategies.
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inTrODUcTiOn
Differences in the expression of biological molecules in the immune cells of newborns and 
adults contribute to diverse cell function and atopic properties (1–5). These immune differences 
are reflected in varied immune responses, cellular subset composition, cytokine production, 
and cellular/humoral protein levels (3, 4, 6, 7). Other mediators including interleukin (IL)-10, 
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prostaglandin E2, and progesterone produced by the placenta 
can also upregulate Th2 differentiation, resulting in down-
regulation of Th1 responses (8–10). In the previous studies, we 
found that neonates have selectively impaired IFNα-mediated 
Th1 immune responses (3, 11). By using proteomic tools, we 
identified at least 34 differentially expressed proteins between 
adult peripheral blood mononuclear cells (PBMCs) and cord 
blood mononuclear cells (CBMCs). There were also validated 
cytoskeletal differences between PBMCs and CBMCs (12). 
Moreover, we observed a decrease in adenosine deaminase 
and an increase in arginase-1 in neonatal mononuclear 
cells (MNCs), which was associated with impaired immune 
function (6). Different modulatory effects of adenosine and 
l-arginine on neonatal and adult leukocytes have also been 
investigated (4).
microRNAs (miRNAs) are small (19–22  nt) single-stranded 
non-coding RNA molecules derived from hairpin-structured 
precursors (13). These miRNAs function by directly binding to the 
indicated 3′-untranslated region of specific target mRNA, leading 
to target mRNA degradation or translational repression. miRNAs 
have been shown to play important roles in human development, 
cellular differentiation and homeostasis, adaptation, oncogenesis, 
and host cell interactions with pathogens (14–16). miRNAs are 
also involved in the regulation of immune systems, indicating 
that they modulate many aspects of the immune response, such 
as differentiation, proliferation, and activation of intracellular 
signaling pathways (17–19).
Recently, the essential regulatory roles of specific miRNAs 
in neonatal immune responses have also been noted. miR-184 
was reported to regulate NFAT1 in neonatal CD4 T cells (20), 
while miR-146a and miR-155 downregulated toll-like receptor 
(TLR) signals in neonatal monocytes and plasmacytoid dendritic 
cells (pDCs), respectively (21, 22). We also found that miR-125b 
negatively regulates LPS-induced TNF-α expression in neonatal 
monocytes (23). It is possible that there is greater diversity in 
miRNA expression in neonatal leukocytes, which may contribute 
to the unique immunity of neonates.
Accumulating evidence demonstrates that miRNAs show 
specific signatures in different blood cell lineages and various 
stages of cellular differentiation (24–26). Since different cell 
types have unique functions and correspondingly, distinct 
gene expression profiles, determining the specificity of miRNA 
expression profiles in different leukocyte subpopulations is very 
important for both understanding the biology of the immune 
system and for characterization. Our hypothesis is that distinct 
miRNA profiles of different leukocyte subpopulations from 
neonatal and adult samples contribute to their relatively differ-
ent immune responses. To exhibit proper immune functions, 
the immune cells must undergo activation, proliferation, and 
cytokine production upon encountering antigens (27). The 
miRNA profiles of leukocytes from neonates and adults have 
been widely reported. However, an important limitation of 
these studies was that they did not directly compare activated 
leukocytes of cord blood (CB) with those from adult periph-
eral blood, but instead used resting leukocytes. This approach 
is not as informative for identifying true differences in the 
functional transcriptome. In other studies, total leukocytes 
were investigated rather than unique leukocyte subsets (28). 
This approach is also information limiting because leukocyte 
subsets have distinct functions. In this study, we set out to 
comprehensively analyze the miRNA expression signatures 
of eight leukocyte subsets [polymorphonuclear cells (PMNs), 
monocytes, CD4+ T cells, CD8+ T cells natural killer (NK) cells, 
B cells, pDCs, and myeloid dendritic cells (mDCs)] between 
neonatal and adult samples. The miRNA profile of activated 
and resting leukocytes was also analyzed. With this functional 
approach, we provide differential miRNA expression profiling 
of specific immune cell subsets between neonates and adults. 
This provides a basis for further understanding of the altered 
immune response in neonates and can guide the development 
of novel therapeutic strategies.
MaTerials anD MeThODs
collection of human Umbilical cord  
Blood and adult Peripheral Blood and  
cell separation
Human umbilical CB was collected in heparinized tubes (10 U/
ml) by cordocentesis at the time of elective Cesarean section or 
normal spontaneous delivery of healthy mothers, following the 
receipt of informed consent. About 20–50 ml of CB was obtained 
from each case. The peripheral blood samples were obtained 
from healthy adult volunteers aged 20–40 years. Approximately 
50–100  ml of blood was obtained from each healthy adult 
depending on the experimental design. Heparinized blood 
samples were collected, and the plasma was stored at −80°C 
before analysis. The leukocyte separation protocol was utilized 
as previously described (11, 12). Briefly, whole blood was 
mixed with 4.5% (w/v) dextran (Amersham Pharmacia Biotech, 
Uppsala, Sweden) sedimentation at a ratio of 1:5 to separate 
leukocytes from red blood cells (RBCs) for 30 min. Leukocytes 
were then separated into PMNs and MNCs by density gradient 
centrifugation in Ficoll-Plaque™ (Amersham Pharmacia) at a 
ratio of 2:1 at 1,500 rpm for 30 min at 20°C. After centrifugation 
over a Ficoll cushion, MNCs were washed and counted on a 
hemocytometer by trypan blue staining. The PMN fraction in 
MNCs was less than 1% in adult and neonate samples. The study 
protocol was approved by the institutional review board of the 
study hospital.
cell separation and enrichment
CD4+ T-cells, CD8+ T-cells, CD14+ monocytes, or CD56+ NK 
cells were separated from MNCs using the IMag Cell Separation 
Systems (BD Biosciences, San Jose, CA, USA) following the 
protocol supplied by the manufacturer. In brief, per 2 × 107 of 
MNCs pellet was suspended in 100 µl of anti-human CD4, CD8, 
CD14, or CD56 magnetic particles (BD Biosciences) and incu-
bated at room temperature for 30 min. Then, the labeled cells 
were resuspended in 1× BD IMag™ buffer, and the tubes were 
placed in the BD Imagnet™ (BD Biosciences) for 10 min. With 
the tube in the BD IMagnet™, the supernatant was removed 
to discard the undesired leukocytes. To maximize purity, the 
FigUre 1 | Distinct microrna (mirna) expression between adult and neonatal leukocytes. (a) Neonate leukocyte subsets show distinct miRNA 
expression compared to adult leukocytes. Heat map showing distinct expression of miRNAs from different leukocyte subsets of adult peripheral blood (left) and cord 
blood (right). Each heat map lane represents the top 100 expressed miRNAs in each leukocyte subset. Higher intensity is shown in red and lower intensity in blue. 
(B) Myeloid and lymphoid leukocytes have unique miRNA profiles. Heat map showing distinct expression of miRNAs from myeloid (polymorphonuclear cells, CD14+ 
monocytes, and myeloid dendritic cells) and lymphoid (CD4+ T cells, CD8+ T cells, and CD19+ B-cells) leukocyte subsets. Thirty-seven miRNAs with the highest 
transcript levels across all tested cell lineages were shown. Higher intensity is shown in red and lower intensity in green.
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process was repeated three times. Then, the indicated cell frac-
tion was carefully washed and suspended in PBS or medium. For 
pDCs isolation, dead cells were initially depleted by magnetic 
negative selection with Dead Cell Removal Kit (Miltenyi. Biotec, 
Bergisch Gladbach, Germany), then per 5 × 107 of MNCs pel-
let was isolated with 50  µl of CD304 (BDCA-4)-microbeads 
(Miltenyi Biotech) and magnetic columns according to the 
manufacturer’s instructions. The mDCs were isolated by mag-
netic positive selection with CD1c (BDCA-1)-microbeads and a 
magnetic column (Miltenyi Biotech) following the depletion of 
CD19+ cells. The purity of isolated cells was confirmed by flow 
cytometry, and all isolated cells demonstrated greater than 90% 
purity (12).
cell culture and stimulation
Approximately 1 ml of leukocytes (2 × 106 cells/ml) suspended 
in RPMI-1640 medium containing 10% heat-inactivated fetal 
bovine serum were co-cultured with and without the indicated 
FigUre 2 | common and unique microrna (mirna) transcripts exist in adult and neonatal leukocyte subsets. 
(Continued)
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stimulatory agents in 24-well culture plates. The cells were 
incubated in a humidified atmosphere of 5% CO2 at 37°C. PMNs, 
monocytes, and mDCs were stimulated with LPS (100  ng/
ml) for 6 h and CD4+ and CD8+ T cells, B-cells, and NK cells 
were stimulated with PHA (5 µg/ml) for 24 h. The stimulation 
condition for pDCs was CpG-ODN 2,216 (5 µg/ml) for 16 h as 
previously reported (29). Cells were harvested after culture and 
subjected to miRNA expression analysis.
rna isolation
Total RNA was extracted using the TRIzol® Reagent (Invitrogen, 
USA) according to the manufacturer’s instructions. Purified RNA 
was quantified at OD260 nm using a ND-1000 spectrophotometer 
(Nanodrop Technology, USA) and qualitatively analyzed using 
a Bioanalyzer 2100 (Agilent Technology, USA) with RNA 6000 
nano lab-chip kit (Agilent Technologies, USA).
rna labeling and hybridization
Total RNA (0.1  µg) was dephosphorylated and labeled with 
pCp-Cy3 using the Agilent miRNA Complete Labeling and Hyb 
Kit (Agilent Technologies, USA, microRNA Spike-In Apply). 
Hybridization buffer (2×) (Agilent Technologies, USA) was 
added to the labeled mixture at a final volume of 45  µl. The 
mixture was heated for 5 min at 100°C and immediately cooled 
to 0°C. Each 45 µl sample was hybridized onto an Agilent human 
miRNA Microarray R19 (Agilent Technologies, USA) at 55°C 
for 20  h. After hybridization, slides were washed for 5  min in 
Gene Expression Wash Buffer 1 at room temperature and then 
washed for 5  min in Gene Expression Wash Buffer 2 at 37°C. 
Microarrays were scanned using the Agilent microarray scan-
ner (Agilent Technologies, model G2505C) at 535 nm for Cy3. 
Feature Extraction (Agilent Technologies) software version 
10.7.3.1 was used for image analysis. If both channels produced 
intensities less than 100 for a given miRNA, that spot was filtered 
out. For spots with one channel intensity less than 100 and the 
other 100 or greater, the signal that was less than 100 was set to 
100 prior to calculation of the signal ratio. Hierarchical cluster-
ing was performed using the Genesis software (Graz University 
of Technology), and Pearson’s correlation was calculated as the 
distance metric.
mirna array
In this study, we used Agilent SurePrint Human miRNA 
Microarray chips (Release 19.0, Agilent Technologies, Santa 
Clara, CA, USA) to globally evaluate the miRNA expression 
FigUre 2 | continued  
(a) Venn diagrams showing comparative analysis of common and unique miRNA transcripts in the corresponding adult and cord blood (CB) leukocyte subsets 
(array intensity log 2 greater than 6). (B) Venn diagrams showing comparative analysis of common and unique miRNA transcripts in the corresponding adult and CB 
leukocyte subsets (array intensity log 2 greater than 10). Abbreviations: AD-C, adult blood cells without stimulation; CB-C, cord blood cells without stimulation; 
AD-T, adult blood cells with stimulation; CB-T, cord blood cells with stimulation.
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profiles of the samples. The extracted RNA samples were first 
subjected to quality examination with a Bioanalyzer to check 
whether they passed the criterion, RIN ≥ 7.0. Then, 0.5 µg of the 
qualified RNA samples were prepared using the Agilent SurePrint 
Human miRNA Microarray kits, followed by microarray chip 
assays. The generated microarray data were analyzed with Partek 
(Partek Inc., St. Louis, MO, USA) under quantized normalization 
and log 2 transformation. Total 32 miRNA array chips were used 
for 8 kinds of leukocytes with/without indicated stimulation from 
CB and adult peripheral blood.
Quantitative reverse Transcription Pcr 
(qrT-Pcr) analysis of mirnas
Total RNA was extracted from the cell pallet using TRIzol® 
reagent (Invitrogen, Carlsbad, CA, USA) according to the 
manufacturer’s protocol. qRT-PCR analysis was performed based 
on two-step qRT-PCR (30). Briefly, in the reverse transcription 
(RT) step, each RNA sample was reverse transcribed to cDNA 
using the TaqMan® miRNA Reverse Transcription Kit (#PN 
4366597, Applied Biosystems, Foster City, CA, USA). Each 
reaction contained 10 ng of RNA, 50 U of Multiscribe Reverse 
Transcriptase, 100 mM of deoxyribonucleotide triphosphate, 1× 
reaction buffer, 4U of RNase inhibitor, and 1× specific miRNA 
primers (TaqMan MicroRNA Assay, PN 4427975, Applied 
Biosystems) with nuclease-free H2O to 15 µl of final volume. The 
reaction mixture was then incubated at 16°C for 30 min, followed 
by incubation at 42°C for 30 min. The enzyme was then inacti-
vated at 85°C for 5 min. In the TaqMan real-time PCR step, 2 µl of 
cDNA solution was amplified using 1× specific miRNA primers 
(TaqMan MicroRNA Assay), 1× TaqMan Universal Master Mix II 
(#PN 44440040, Applied Biosystems, Darmstadt, Germany), and 
nuclease-free H2O to 10 µl of final volume. Quantitative PCR was 
performed on a 7500 System quantitative PCR machine (Applied 
Biosystems, Darmstadt, Germany) using a two-step PCR proto-
col with a denaturation step at 95°C for 10 min, followed by 40 
cycles with a denaturation step at 95°C for 15 s, and an annealing/
elongation step at 60°C for 60 s. The cycle threshold (Ct) values 
were calculated using the SDS 2.1 software (Applied Biosystems, 
Darmstadt, Germany). The relative amount of miRNA to small 
nuclear U6 snRNA (the internal control) was calculated using the 
equation 2–∆CT, where ΔCt = (Ct microRNA—Ct U6RNA) data 
FigUre 3 | Differential microrna (mirna) profiles between adult and neonatal polymorphonuclear cells (PMns). Upper heat map showing distinct 
miRNA expression in activated and resting leukocyte subsets of adult peripheral blood and cord blood. Each heat map lane represents the top 100 expressed 
miRNAs in each leukocyte subset. Higher intensity is shown in red and lower intensity in blue. Lower bar charts showing the top 10 differentially expressed miRNAs 
in adult (black bar) or (white bar) neonate cells in specific leukocytes at resting (left) or activated states (right). The expression of miRNAs is represented as relative 
folds. Has, Homo sapiens.
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were analyzed as previously described (31). The target miRNA 
primer sequences were as follows: hsa-let-7b-5p (002619): 5′-
UGA GGU AGU AGG UUG UGU GGU U-3′; hsa-miR-29a-3p 
(002112): 5′-UAG CAC CAU CUG AAA UCG GUU A-3′; hsa-
miR-29b-3p (000413): 5′-UAG CAC CAU UUG AAA UCA GUG 
UU-3′; hsa-miR-130a-3p (000454), 5′-CAG UGC AAU GUU 
AAA AGG GCA U-3′. hsa-U6 snRNA (001973).
Transfection of let-7b-5p Mimic and 
inhibitor with Functional Validation
A total of 2.5 × 105 cells/0.5 ml primary human CD14+ monocytes 
were maintained in RPMI-1640 medium supplemented with 10% 
FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/
ml Amphotericin B (GIBCO) at 37°C in a humidified incubator 
containing 5% CO2. For functional analysis, Has-let-7b-5p mimics 
FigUre 4 | Differential microrna profiles between adult and neonatal cD4+ T cells.
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(#47-775, EXIQON, TGAGGTAGTAGGTTGTGTGGTT), Has-
let-7b-5p miRCURY LNA™ microRNA inhibitor (#4100945, 
EXIQON, ACCACACAACCTACTACCTC), cel-miR-39-3p 
miRCURY LNA™ microRNA Mimic Negative Control 
(#479902, EXIQON, TCACCGGGTGTAAATCAGCTTG), 
and miRCURY LNA™ microRNA inhibitor scramble control 
(#199900, EXIQON, ACGTCTATACGCCCA) were used. The 
miR mimics and LNA inhibitors were transfected into CD14+ 
cells using TransIT-X2 (Mirus, Madison, WI, USA) according 
to the manufacturer’s instructions. Briefly, cells were plated in a 
48-well plate. miR mimics (50 µl) or LNA inhibitors and 1.5 µl 
of TransIT-X2 Transfection Reagent were added separately to 
450  µl of RPMI-1640 medium (Invitrogen). The solution was 
then mixed to form the transfection complex. The transfection 
complex was added to cells with a final working concentration 
20 or 40 nM and incubated at 37°C for 24 or 48 h, as indicated. 
After incubation with the transfection complex, the transfected 
cells were stimulated with or without LPS (100 ng/ml) for 16 h. 
The culture supernatants were then collected for quantification 
of IL-6, IL-8, and TNF-α production by ELISA (R&D Systems, 
Minneapolis, MN, USA, catalog number DY260,208 and DY210).
statistics
Data are expressed as the mean ± SEM. The Mann–Whitney U test 
was used when two groups were analyzed. Results with a p-value 
of less than 0.05 were considered to be statistically significant. All 
FigUre 5 | Differential microrna profiles between adult and neonatal cD8+ T cells.
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statistical tests were performed using the SPSS 19.0 for Windows 
XP (SPSS, Inc., Chicago, IL, USA).
resUlTs
hierarchical clustering of adult Peripheral 
Blood and cord Blood leukocyte 
subpopulations Based on mirna 
expression
According to the manufacturer’s design, probe sets displaying a 
log 2 signal value greater than 6 were linear and therefore reli-
able for miRNA analysis. Using data from the pooled samples, 
specific probe sets displayed an average log 2 signal value greater 
than 6 in at least one cell type and were deemed to be expressed 
above background. PMNs, CD4+ T cells, CD8+ T cells, CD14+ 
monocytes, and CD56+ NK cells were isolated from healthy 
adult peripheral or CB obtained from pools of five donors each. 
The BDCA1+ mDCs were obtained from pools of 10 healthy 
adult peripheral or CB donors. The BDCA4+ pDCs were 
obtained from pools of 19 healthy adult peripheral blood and 
31 CB donors for its little amount. Subjects were randomized 
across pools for gender. We chose to pool samples in order to 
get sufficient cell numbers for rare cell types and to decrease 
sample variation. Because of the rare amount of dendritic cells, 
normalized miRNA expression data from one chip array with 
FigUre 6 | Differential microrna profiles between adult and neonatal cD14+ monocytes.
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pooled leukocytes were analyzed in this study. The array data 
have been submitted to GEO and assigned an accession number 
“GSE89853.” The raw data are now available and open for the 
researcher community. Full lists of normalized miRNA expres-
sion are shown in Table S1 in Supplementary Material. An 
unsupervised hierarchical cluster analysis of the top 100 most 
abundant miRNAs revealed discrete miRNA profiles for adult 
and CB leukocyte subsets, including unique miRNA signatures 
for each cell lineage (Figure 1A).
In order to characterize the specific miRNA expression 
between myeloid and lymphoid leukocytes, adult leukocyte sub-
sets were divided into myeloid (PMNs, monocytes, and mDCs) 
and lymphoid groups (CD4+, CD8+ T cells, and CD19+ B-cells). 
The miRNA profiles of these two groups were compared as shown 
in Figure  1B. Samples from the same origin (myeloid or lym-
phoid) had similar miRNA expression profiles and were clustered 
together. Myeloid and lymphoid leukocytes have unique miRNA 
profiles that demonstrate the difference in their development. 
miR-744-5p, miR-4763-3p, miR-1207-5p, miR-3656, and miR-
6090 were predominantly expressed in myeloid cells. In contrast, 
let-7g-5p (especially in CD4+ T cells), miR-342-3p, miR-324-3p, 
miR-3607-3p, miR-215 (especially in CD8+ T cells), let-7a-5p, 
miR-95, miR-151a-3p, miR-222-3p, miR-3127-5p, miR-4284, 
and miR-3609 (especially in B-cells) were expressed mainly in 
FigUre 7 | Differential microrna profiles between adult and neonatal cD19+ B-cells.
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lymphoid cells. Interestingly, two members of the let-7 family 
(let-7a-5p and let-7g-5p) were present in the set of abundantly 
expressed miRNAs in lymphoid cells.
mirna signature Distinguished adult  
and neonatal leukocyte subsets
A lower filter threshold (log 2 signal value greater than 6) was 
initially set for miRNA analysis. Adult CD14+ monocytes dem-
onstrated higher miRNA expression (269 miRNAs) than other 
leukocyte subsets, while adult pDCs had the lowest miRNA 
expression (98 miRNAs) (Table S2 in Supplementary Material). 
When comparing adult and CB leukocyte subsets, the Venn 
diagrams also showed common and unique miRNA transcripts 
in indicated leukocytes before and after stimulation (Figure 2). 
There were significant overlaps between adult and neonatal leu-
kocyte subsets. We also applied a higher filter (log 2 signal value 
greater than 10) to identify the highly expressed miRNA tran-
scripts among the different leukocyte subsets. With the higher 
filter, adult CD14+ monocytes had the highest number of miRNAs 
(66 miRNAs) compared to other leukocyte subsets, while adult 
pDCs had the lowest number of miRNAs (13 miRNAs) (Table 
S2 in Supplementary Material). Figure  2B demonstrates the 
common and unique miRNA transcripts in indicated leukocytes 
FigUre 8 | Differential microrna profiles between adult and neonatal cD56+ natural killer cells.
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subsets between adult and CB with the higher filter. Significant 
overlaps between the adult and neonatal leukocyte subsets 
were also observed with the higher filter range. Using a higher 
filter, mDCs had the least overlap of miRNAs between adult and 
neonatal leukocytes (5/26; 19.2% overlap). These common and 
unique miRNA transcripts detail between indicated adult and CB 
leukocyte subsets in Table S3 in Supplementary Material.
leukocytes mirna signature  
altered after stimulation
Since the major roles of immune cells are to defend the body 
against foreign substances, stimulation is needed to activate 
immune responses. Therefore, we also compared the miRNA 
profiles of leukocyte subsets between adult and neonate samples 
upon stimulation. Among the differentially expressed miRNA, 
the top 20 miRNAs expressed in specific leukocytes from adult 
(more than or less than neonate) samples were chosen and 
illustrated. The differentially expressed miRNA profiles of PMNs, 
CD4+ T cells, CD8+ T cells, CD14+ monocytes, CD19+ B-cells, 
CD56+ NK cells, mDCs, and pDCs are shown in Figures 3–10, 
respectively. Under resting conditions, compared to adult coun-
terparts, the top 10 underexpressed miRNAs in CB PMNs were 
let-7b-5p, let-7c, miR-4516, miR-4466, miR-4281, miR-2861, 
miR-1225-5p, miR-6090, miR-1234-5p, and miR-3663-3p. The 
FigUre 9 | Differential microrna profiles between adult and neonatal myeloid dendritic cells.
12
Yu et al. microRNA Profiling of Neonatal Leukocytes
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 615
top 10 miRNAs (miR-586, miR-451a, miR-17-5p, miR-145-5p, 
miR-6127, miR-199a-3p, miR-3135b, miR-423-5p, miR-3651, 
and miR-93-5p) were overexpressed in CB PMNs (Figure  3). 
Upon LPS stimulation, compared to adult counterparts, the top 
10 underexpressed miRNAs in CB PMNs were miR-142-5p, let-
7c, let-7b-5p, miR-101-3p, miR-3676-5p, miR-494, miR-29c-3p, 
miR-2861, miR-1915-3p, and miR-4466, while the top 10 miRNAs 
overexpressed in CB PMNs were miR-451a, miR-17-5p, miR-
199b-5p, miR-320d, miR-199a-3p, miR-361-5p, miR-342-3b, 
miR-15b-5p, miR-181a-5p, and miR-20a-5p (Figure  3). With 
LPS stimulation, miR-142-5p exhibited the highest expression in 
adult PMNs compared to CB PMNs and miR-451a showed the 
highest expression in neonatal PMNs compared to adult PMNs. 
let-7b-5p and miR-142-5p exhibited the highest expression in 
adult PMNs compared to neonatal PMNs at resting and activated 
states, respectively. miR-586 and miR-451a exhibited the highest 
expression in cord PMNs compared to adult PMNs at resting 
and activated states, respectively. These dynamic changes in 
miRNA profiles correspond to the functional roles of miRNAs 
in immune cells during stimulation. Similarly, miR-1238-3p 
exhibited the highest expression in adult CD4+ T cells compared 
to neonatal CD4+ T cells at resting state (Figure 4). miR-19a-5p 
FigUre 10 | Differential microrna profiles between adult and neonatal plasmacytoid dendritic cells.
13
Yu et al. microRNA Profiling of Neonatal Leukocytes
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 615
had the highest expression in neonatal CD4+ T cells compared 
to adult CD4+ T-cells at resting state. With PHA stimulation, 
miR-551b-3p exhibited the highest increase in expression in 
adult CD4+ T cells. miR-518c-3p showed the highest expres-
sion in neonatal CD4+ T cells compared to adult CD4+ T cells 
after PHA stimulation. Interestingly, let-7b-5p exhibited higher 
expression in adult monocytes compared to neonatal monocytes 
with or without stimulation (Figure 6). Likewise, we identified 
unique miRNA profiles of other leukocyte subsets between adults 
and neonates with or without stimulation. These unique miRNA 
profiles between adult and neonate leukocytes likely contribute 
to the altered immune function of neonates. It is noteworthy that 
adult peripheral leukocytes consistently demonstrated higher let-
7b-5p and lower miR-181a-5p expression than CB cells across 
multiple subsets, with or without stimulation.
Since the differentially expressed miRNAs were selected based 
on signal intensity from a chip array with pooled leukocytes, we 
selected let-7b-5p, miR-29a-3p, miR-29b-3p, and miR-130a-3p 
to validate the array results by qRT-PCR in PMN, CD4+ T cells, 
and CD14+ monocytes. As shown in Figure  11, the qRT-PCR 
FigUre 11 | Quantitative reverse transcription Pcr (qrT-Pcr) validation of let-7b-5p, 29a-3p, 29b-3p, and mir-130a-3p expression in various 
leukocyte subsets from cord blood (cB) and adult peripheral blood. 
(Continued)
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FigUre 11 | continued  
To validate the data derived from our microarray analysis and literature references, we subjected RNA extracts harvested from stimulated or unstimulated 
polymorphonuclear cell, CD4+ T cells, and CD14+ monocytes of neonatal and adult samples for qRT-PCR analysis of let-7b-5p, miR-29a-3p, miR-29b-3p, and 
miR-130a-3p expression *p < 0.05 between indicated adult and CB leukocytes without stimulation; #p < 0.05 between indicated adult and CB leukocytes with 
stimulation; §p < 0.05 between indicated CB leukocytes without and with stimulation (by ANOVA with the LSD post hoc test, n = 4).
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results demonstrated a decrease in the expression of miR-29a-3p 
in PMNs and CD4+ T cells of CB compared to adult cells, as 
opposed to CD14+ monocytes. A similar trend to miR-29a-3p 
was observed with the expression of miR-29b-3p, whereas the 
expression of miR-130a-3p was higher in neonatal PMN, CD4+ 
T cells, and CD14+ cells. These data were consistent with the 
microarray results.
Functional Validation of let-7b-5p on  
Pro-inflammatory cytokine Production  
by Monocytes
In the next study, monocytes were selected for further func-
tional validation of let-7b-5p. Because adult monocytes had 
higher let-7b-5p expression than CB, we transfected a let-7b-5p 
inhibitor and let-7b-5p mimic into adult monocytes and CB 
monocytes, respectively. The transfection efficiency of the 
let-7b-5p inhibitor and mimic were determined by qPCR. As 
shown in Figure S1 in Supplementary Material, transfection 
of the let-7b-5p inhibitor into adult monocytes for 24 h sup-
pressed let-7b expression 0.05-fold (at 20 and 40  nM of let-
7b-5p inhibitor), white transfection of the let-7b-5p mimic into 
CB monocytes enhanced the expression of let-7b-5p 16,000- (at 
20 nM of let-7b-5p mimic) and 20,000-fold (at 40 nM let-7b-5p 
mimic).
The function of let-7b-5p on the pro-inflammatory cytokine 
production was determined. Upon LPS stimulation, the 
monocytes produced large amounts of IL-6, IL-8, and TNF-α. 
Cord blood monocytes showed higher IL-6 (12,265 ± 1,387 vs. 
4,623 ± 1,474 pg/ml) and TNF-α (2,436 ± 706 vs. 536 ± 54 pg/
ml) production than adult monocytes (Figure 12). Transfection 
of the let-7b-5p inhibitor (20 nM) into adult monocytes for 24 h 
enhanced IL-6 production (Figure  13A). Transfecting the let-
7b-5p mimic into CB monocytes for 24 h did not significantly 
suppress IL-6 production, although there was a trend. After trans-
fecting let-7b-5p mimic into CB monocytes for 48 h, IL-6 produc-
tion was suppressed with 40 nM of let-7b-5p mimic (Figure 13B). 
Transfection of the let-7b-5p inhibitor at 20 and 40 nM for 24 h 
enhanced TNF-α production by adult monocytes (Figure 14A). 
However, transfection of let-7b-5p mimic at 20  nM for 48  h 
was needed to suppress TNF-α production by CB monocytes 
(Figure 14B). These results suggest that the modulatory effects of 
CB monocytes could be achieved with let-7b mimic, but a longer 
incubation time is needed. Either transfection with the let-7b-5p 
inhibitor or let-7b-5p mimic for 24 or 48 h had no influence on 
IL-8 production by adult or CB monocytes (Figures 15A,B).
DiscUssiOn
Blood contains different leukocyte subsets owning distinct gene 
expression profiles corresponding to distinct immune functions 
upon stimulation. Since miRNA behavior at the molecular 
level is context and cell type dependent, knowing the distinct 
functions of specific mRNAs in adult and neonatal leukocyte 
subsets can help to clarify the mechanisms leading to altered 
immunity in newborns. In this study, we conducted a systematic 
and comprehensive analysis of functional miRNAs in purified 
PMN, monocytes, T cells, NK cells, B cells, pDCs, and mDCs 
from neonates and adults. Transfection of the let-7b inhibitor 
into adult monocytes significantly enhanced IL-6 and TNF-α 
production, while transfection of a let-7b mimic into CB mono-
cytes significantly suppressed the production of these cytokines. 
Accordingly, functional validation identified higher IL-6 and 
TNF-α production by CB monocytes than adult monocytes upon 
FigUre 12 | adult and cord blood (cB) monocytes produced large amounts of pro-inflammatory cytokines upon lPs stimulation. Adult and CB 
monocytes were stimulated with LPS for 16 h, and then the supernatant was collected for quantification of (a) interleukin (IL)-6, (B) IL-8, and (c) TNF-α secretion. 
*p < 0.05 between adult and CB monocytes with Mann–Whitney U test (n = 5).
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LPS stimulation. This is, at least partly, due to their lower let-7b 
expression. Our results demonstrate the essential roles of specific 
miRNAs in regulating neonatal immune functions and provide 
insight into the molecular mechanism.
Understanding of the immune response in disease is an 
important issue for living organisms. The immune system is a 
complex system of interacting cells whose primary purpose is to 
identify foreign substances. To exhibit proper immune function, 
the immune cells must undergo activation, proliferation, and 
cytokine production upon encountering antigens (27). Therefore, 
activated leukocyte subsets have more biological transcripts than 
resting cells (3, 23). In order to investigate the corresponding 
innate or adaptive immune response, leukocyte subsets were 
isolated and stimulated with LPS, PHA, or CpG ODN as indicated 
in this study. LPS is a component of Gram-negative bacteria and 
is used in in vitro studies to assess innate immune responses to 
Gram-negative bacterial infection (32, 33). PHA is a lectin that 
binds to the sugars on glycosylated surface proteins, including 
FigUre 13 | The effect of let-7b-5p on interleukin (il)-6 production by monocytes. let-7b-5p inhibitor transfected or untransfected adult monocytes and 
let-7b-5p mimic transfected and untransfected CB monocytes were subjected to detection of the IL-6 protein after LPS stimulation for 16 h. The transfection times 
were (a) 24 h and (B) 48 h. IL-6 production is represented as relative fold expression compared to the LPS stimulation control. *p < 0.05 as compared with LPS 
stimulation only with Mann–Whitney U test (n = 5).
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the T cell receptor, and thereby crosslinks T cell activation signals. 
PHA has been widely used to stimulate human lymphocytes (34), 
whereas unmethylated CpG ODN is a ligand for TLR9 of pDCs 
(29). We chose LPS as a stimulus for PMN, monocytes, and 
mDCs. PHA was used to stimulate lymphocytes and NK cells, 
while CpG ODN was used to stimulate pDCs. With this approach, 
we provide functionally differential miRNA expression profiling 
of specific immune cell subsets between neonates and adults.
Although some studies have reported differences in miRNA 
expression between cord and adult blood immune cells, most 
focused on the miRNA profiles of a single resting leukocyte 
subpopulation (20, 22, 35). Several studies have provided miRNA 
profiles for limited leukocyte subsets without comparing to 
adults, thus providing only limited array information (28, 36, 37). 
Our study identified many previously reported miRNAs as well 
as unidentified miRNAs in all leukocyte subsets. We determined 
that all adult leukocyte subsets show higher let-7b-5p expression 
than the corresponding CB leukocytes, irrespective of their 
activation state. The let-7 miRNA family has been reported to 
consistently demonstrate increased abundance in adult erythroid 
cells (38).
To the best of our knowledge, this study is the first to demon-
strate the abundance of let-7b-5p in all adult leukocyte subsets 
compared to neonates. Our data also demonstrate that neonatal 
CD4+ T cells have more abundant miR-181a expression than 
adult CD4+ T cells as previously reported by Palin et  al. (35). 
Furthermore, our data show that all neonatal leukocyte subsets 
have more abundant miR-181a expression than relevant cells in 
adults, besides CD4+ T cells. Our findings also correlate with that 
of Charrier et al. showing that neonatal pDCs have more abun-
dant TLR signal-related miR-155-5p (called miR-155 previously) 
expression than adult pDCs at the resting state (22). Moreover, we 
found that miR-155-5p expression in adult pDCs is upregulated 
and compatible with neonatal pDCs after CPG ODN stimulation. 
Our study confirms the overexpression of miR-15b, miR-181a, 
miR-363, and miR-424 in CB CD4+ and CD8+ T cells, as previ-
ously reported (37). However, we did not observe significant 
change in miR-155 expression after LPS stimulation in our array 
data, as reported by Takahashi et al. (37). The dynamic changes 
of miR-155 presented in our previous study could explain this 
inconsistency (23). Higher miR-184 expression in CB CD4+ 
T cells that regulate the abundance of NFAT1 has been reported 
18
Yu et al. microRNA Profiling of Neonatal Leukocytes
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 615
FigUre 14 | The effect of let-7b-5p on TnF-α production by monocytes. Adult monocytes with or without let-7b-5p inhibitor transfection and cord blood 
monocytes with or without let-7b-5p mimic transfection were subjected to detection of TNF-α protein after LPS stimulation for 16 h. The transfection times were  
(a) 24 h and (B) 48 h. TNF-α production is represented as relative fold expression compared to the LPS stimulation control. Data presented are calculated from five 
replicate measurements. *p < 0.05 as compared with LPS stimulation only with Mann–Whitney U test (n = 5).
(20). However, our data showed low miR-184 expression below 
the threshold setting, in adult and cord CD4+ T cells. Three 
small-RNA transcripts were expressed specifically in one cell 
type: miR-378 in monocytes, miR-31 in T cells, and miR-143 in 
neutrophils (25). In our study, we did observe specific miR-143 
in neutrophils, although miR-378 and miR-31 were selectively 
expressed in adult and neonatal monocytes and T cells, respec-
tively. These inconsistent results in miRNA expression among 
the different studies might be due to the differences of array or 
isolation kits used for study.
Based on our data, all adult leukocyte subsets illustrated 
higher let-7b-5p expression than the corresponding CB leuko-
cytes. The higher let-7b-5p expression in adult leukocyte subsets 
was 3.7- to 63.0-fold that of neonates (Table S1 in Supplementary 
Material). PHA-stimulated adult CD4+ T cells and CD8+ T cells 
had higher let-7b-5p expression than neonates (63.0- and 40.2-
fold, respectively).
let-7 is an important miRNA family consisting of 13 members. 
They are highly conserved across several animal species (39). 
The role of let-7 family members in tumor suppression is well 
established, and their role in the regulation of innate immunity is 
slowly being unveiled. Teng et al. have shown that let-7b regulates 
the expression of TLR4 via posttranscriptional suppression and 
subsequently influences the activation of NF-κB and downstream 
gene expression (40). Type 1 IFN production and antiviral signal-
ing cascades are an important defense mechanism in the innate 
immune response to viral infections. let-7b has also been shown 
to regulate type 1 IFN production and can inhibit HCV replica-
tion and viral protein translation through insulin-like growth 
factor 2 mRNA-binding protein 1 (41–43). Whether diminished 
let-7b expression in neonatal leukocyte subsets can lead to altered 
type 1 IFN production and the susceptibility of newborns to viral 
infections need further investigation (1, 29). In our study, let-
7b-5p modulated IL-6 and TNF-α production by monocytes. It 
has been suggested that, with LPS stimulation, hepatocarcinoma 
cells transfect let-7b enriched microparticles into macrophages, 
resulting in IL-6 downregulation in macrophages (44). We 
observed that more abundant let-7b expression in adult mono-
cytes corresponded to lower IL-6 production than in CB mono-
cytes with LPS stimulation. Transfection of adult monocytes 
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with a let-7b-5p inhibitor enhanced IL-6 production, while 
transfection of a let-7b-5p mimic into CB monocytes suppressed 
IL-6 production. This suggests that reduced let-7b expression in 
CB monocytes contributes to higher IL-6 production, compared 
to adult monocytes. Since IL-6 can modulate the recruitment 
and differentiation of T and B lymphocytes (45), let-7b plays an 
important modulatory role in the altered immune responses in 
newborns.
Interleukin-6 is a multifunctional cytokine secreted by many 
kinds of cells. IL-6 is produced in response to TLR ligands and 
other pro-inflammatory cytokines through the NF-κB signaling 
pathway (45). Although let-7b was also reported to target TLR4 
and suppress IL-8 production through NF-κB regulation in gas-
tric epithelial cells with Helicobacter pylori infection (40), there 
are likely different mechanisms for IL-6/IL-8 production control 
in specific cells, as let-7b cannot influence IL-8 production in 
both adult and CB monocytes.
Neonates are susceptible to infection, and neonatal sepsis is 
a significant cause of mortality and morbidity in newborns (46). 
Inflammatory responses are necessary for the host to respond to 
components of invading organisms. At the early stages of infection, 
TNF-α, IL-1β, IL-6, and IL-8 pro-inflammatory cytokines are 
produced and stimulate immune cells leading to activation of an 
inflammatory cascade (47). The subsequent inflammatory cas-
cade includes many biologically active mediators and can induce 
a systemic inflammatory response. The inflammatory response 
is thereafter counteracted by anti-inflammatory mediators to 
restore immunological homeostasis. Excessive pro-inflammatory 
mediators or inadequate anti-inflammatory responses will lead 
to sepsis (47). In addition to antibiotics, other adjuvant therapies 
primarily target the dysregulated innate immune response. 
Pentoxifylline, a xanthine-derived phosphodiesterase inhibitor 
that decreases TNF-α and IL-6 production, has been reported 
to improve the clinical outcome of preterm sepsis (48). Recently, 
anti-cytokine agents in early sepsis with excessive uncontrolled 
hyper-inflammatory state have been addressed (49). Riedemann 
et al. demonstrated that an anti-IL-6 antibody could significantly 
improve survival through reduction of C5aR in various organs in 
a cecal ligation/puncture model in mice (50). Remick et al. also 
showed that the combination of IL-1 receptor antagonist and TNF 
soluble receptor is also effective in this clinically relevant mouse 
model of sepsis (51). Although each strategy has certain benefits, 
FigUre 15 | The effect of let-7b-5p on interleukin (il)-8 production by monocytes. Adult monocytes with or without let-7b-5p inhibitor transfection and cord 
blood monocytes with or without let-7b-5p mimic transfection were subjected to detection of the IL-8 protein after LPS stimulation for 16 h. The transfection times 
were (a) 24 h and (B) 48 h. IL-8 production is represented as relative fold expression compared to the LPS stimulation control. *p < 0.05 as compared with LPS 
stimulation only with Mann–Whitney U test (n = 5).
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